Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mihai G Netea

Showing results (971-980 of 1,312) with videos related to

Pageof 132
Sort By:
Plos One|July 21, 2017
An integrative genomics approach identifies novel pathways that influence candidaemia susceptibilityVasiliki Matzaraki, Mark S Gresnigt, Martin Jaeger, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2021
Immune cells fold and damage fungal hyphaeJudith M Bain, M Fernanda Alonso, Delma S Childers, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 26, 2010
Genetic variation of innate immune genes in HIV-infected african patients with or without oropharyngeal candidiasisTheo S Plantinga, Omar J M Hamza, Janet A Willment, et al.
Open Forum Infectious Diseases|December 12, 2017
Risks of Ruxolitinib in <i>STAT1</i> Gain-of-Function-Associated Severe Fungal DiseaseOfer Zimmerman, Berenice Rösler, Christa S Zerbe, et al.
The Lancet Regional Health. Europe|December 24, 2021
Risk of candidiasis associated with interleukin-17 inhibitors: A real-world observational study of multiple independent sourcesLinda Davidson, Juul M P A van den Reek, Mariolina Bruno, et al.
Open Forum Infectious Diseases|February 3, 2016
The Effect of Rosuvastatin on Markers of Immune Activation in Treatment-Naive Human Immunodeficiency Virus-PatientsRobyn G M Weijma, Eric R A Vos, Jaap Ten Oever, et al.
The Journal of Allergy and Clinical Immunology|May 2, 2016
Immunologic defects in severe mucocutaneous HSV-2 infections: Response to IFN-γ therapyPeer Arts, Frank L van de Veerdonk, Robin van der Lee, et al.
Cell|June 5, 2024
Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone lossHui Wang, Kimon Divaris, Bohu Pan, et al.
Med (New York, N.Y.)|September 27, 2021
Interferon gamma immunotherapy in five critically ill COVID-19 patients with impaired cellular immunity: A case seriesArjan van Laarhoven, Lisa Kurver, Gijs J Overheul, et al.
Frontiers in Immunology|January 29, 2026
Induction of trained immunity in myeloid cells and their progenitors from thyroid cancer patientsPepijn van Houten, Prashant Changoer, Liesbeth van Emst, et al.
Pageof 132

Showing results (971-980 of 1,312) with videos related to

Sort By:
Pageof 132
Plos One|July 21, 2017
An integrative genomics approach identifies novel pathways that influence candidaemia susceptibilityVasiliki Matzaraki, Mark S Gresnigt, Martin Jaeger, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2021
Immune cells fold and damage fungal hyphaeJudith M Bain, M Fernanda Alonso, Delma S Childers, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 26, 2010
Genetic variation of innate immune genes in HIV-infected african patients with or without oropharyngeal candidiasisTheo S Plantinga, Omar J M Hamza, Janet A Willment, et al.
Open Forum Infectious Diseases|December 12, 2017
Risks of Ruxolitinib in <i>STAT1</i> Gain-of-Function-Associated Severe Fungal DiseaseOfer Zimmerman, Berenice Rösler, Christa S Zerbe, et al.
The Lancet Regional Health. Europe|December 24, 2021
Risk of candidiasis associated with interleukin-17 inhibitors: A real-world observational study of multiple independent sourcesLinda Davidson, Juul M P A van den Reek, Mariolina Bruno, et al.
Open Forum Infectious Diseases|February 3, 2016
The Effect of Rosuvastatin on Markers of Immune Activation in Treatment-Naive Human Immunodeficiency Virus-PatientsRobyn G M Weijma, Eric R A Vos, Jaap Ten Oever, et al.
The Journal of Allergy and Clinical Immunology|May 2, 2016
Immunologic defects in severe mucocutaneous HSV-2 infections: Response to IFN-γ therapyPeer Arts, Frank L van de Veerdonk, Robin van der Lee, et al.
Cell|June 5, 2024
Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone lossHui Wang, Kimon Divaris, Bohu Pan, et al.
Med (New York, N.Y.)|September 27, 2021
Interferon gamma immunotherapy in five critically ill COVID-19 patients with impaired cellular immunity: A case seriesArjan van Laarhoven, Lisa Kurver, Gijs J Overheul, et al.
Frontiers in Immunology|January 29, 2026
Induction of trained immunity in myeloid cells and their progenitors from thyroid cancer patientsPepijn van Houten, Prashant Changoer, Liesbeth van Emst, et al.
Pageof 132